Skip to content
HOME Insights

Fact Sheet: Ncyte® Endothelial Cells

Discover cells that are the ideal tool to provide relevant predictions of your drug’s effect on endothelial cell function with Ncardia's fact sheet.
TAKE THE FIRST STEP
Fact Sheet- Ncyte® Endothelial Cells

Discover Ncyte® Endothelial Cells

Ncyte® Endothelial Cells are produced through a well-defined in vitro differentiation process from human induced pluripotent stem cells (iPSC) and express typical endothelial cell markers, such as CD31 and CD144.

These cells are the ideal tool to provide relevant predictions of your drug’s effect on endothelial cell function. They can be utilized over the entire drug discovery process, from the large screening campaigns for hit identification to critical decision-making in hit-2-lead or lead optimization.
Topics
ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.

Download the fact sheet by filling out the form below: